Security key
76152G100
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH)
CUSIP: 76152G100
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 13,730,837
- Total 13F shares
- 1,303,532
- Share change
- +314,002
- Total reported value
- $5,539,575
- Put/Call ratio
- 52%
- Price per share
- $4.25
- Number of holders
- 23
- Value change
- +$1,730,868
- Number of buys
- 20
- Number of sells
- 6
Report period
Q4 2022
Institutions
23
Top holders
10
RVPH full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC filings
REVIVA PHARMACEUTICALS HOLDINGS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76152G100
Recent filing periods:
Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
406,394
|
$646,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.61%
|
83,652
|
$133,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.57%
|
78,075
|
$124,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.53%
|
72,218
|
$115,000 | — | 30 Sep 2022 | |
| EMC Capital Management |
13F
|
Company |
0.4%
|
55,078
|
$275,000 | — | 30 Sep 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.34%
|
46,119
|
$73,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.29%
|
40,232
|
$64,000 | — | 30 Sep 2022 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.24%
|
33,000
|
$52,000 | — | 30 Sep 2022 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
30,000
|
$48,000 | — | 30 Sep 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.16%
|
22,093
|
$35,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.13%
|
17,180
|
$27,000 | — | 30 Sep 2022 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.09%
|
11,839
|
$19,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
10,584
|
$17,000 | — | 30 Sep 2022 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.07%
|
9,299
|
$15,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
4,271
|
$7,000 | — | 30 Sep 2022 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
659
|
$1,000 | — | 30 Sep 2022 | |
| VEDANTA PARTNERS, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
1,127,207
mixed-class rows
|
— | — | 08 Sep 2022 |
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH) as of Q4 2022
As of 31 Dec 2022,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,303,532 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EMC Capital Management, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., XTX Topco Ltd, TWO SIGMA INVESTMENTS, LP, STATE STREET CORP, Cubist Systematic Strategies, LLC, and SABBY MANAGEMENT, LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
15
Q4 2022 holders
23
Holder diff
8
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.